In this observational study, researchers from Boston University School of Medicine (BUSM), investigated the effects of testosterone treatment in 255 hypogonadal men between the ages of 33-69 and followed them for a period of five years.

They found that men treated with testosterone therapy experienced a gradual reduction of their total cholesterol, low density lipoprotein cholesterol, triglycerides and increased high density lipoprotein.